These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12921253)

  • 1. Linezolid clearance during continuous venovenous hemodiafiltration: a case report.
    Kraft MD; Pasko DA; DePestel DD; Ellis JJ; Peloquin CA; Mueller BA
    Pharmacotherapy; 2003 Aug; 23(8):1071-5. PubMed ID: 12921253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance of linezolid via continuous venovenous hemodiafiltration.
    Mauro LS; Peloquin CA; Schmude K; Assaly R; Malhotra D
    Am J Kidney Dis; 2006 Jun; 47(6):e83-6. PubMed ID: 16731287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients.
    Guenter SG; Iven H; Boos C; Bruch HP; Muhl E
    Pharmacotherapy; 2002 Feb; 22(2):175-83. PubMed ID: 11837556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure.
    Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Sagripanti S; Manini P; Andreoli R; Cabassi A
    Crit Care Med; 2004 Dec; 32(12):2437-42. PubMed ID: 15599148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does haemodialysis significantly affect serum linezolid concentrations in critically ill patients with renal failure? A pilot investigation.
    Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Manini P; Andreoli R; Cabassi A
    Nephrol Dial Transplant; 2006 May; 21(5):1402-6. PubMed ID: 16504979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational study.
    Zoller M; Maier B; Hornuss C; Neugebauer C; Döbbeler G; Nagel D; Holdt LM; Bruegel M; Weig T; Grabein B; Frey L; Teupser D; Vogeser M; Zander J
    Crit Care; 2014 Jul; 18(4):R148. PubMed ID: 25011656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases.
    Pea F; Viale P; Lugano M; Pavan F; Scudeller L; Della Rocca G; Furlanut M
    Am J Kidney Dis; 2004 Dec; 44(6):1097-102. PubMed ID: 15558532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid pharmacokinetics in patients with acute renal failure undergoing continuous venovenous hemodiafiltration.
    Carcelero E; Soy D; Guerrero L; Poch E; Fernandez J; Castro P; Ribas J
    J Clin Pharmacol; 2012 Sep; 52(9):1430-5. PubMed ID: 21960670
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacokinetic evaluation of linezolid in patients with major thermal injuries].
    Le Floch R; Arnould JF; Vinsonneau C; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Lovering AM
    Pathol Biol (Paris); 2010 Apr; 58(2):e27-31. PubMed ID: 19854590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and tissue penetration of linezolid following multiple oral doses.
    Gee T; Ellis R; Marshall G; Andrews J; Ashby J; Wise R
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1843-6. PubMed ID: 11353635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of linezolid into sternal bone of patients undergoing cardiopulmonary bypass surgery.
    Metallidis S; Nikolaidis J; Lazaraki G; Koumentaki E; Gogou V; Topsis D; Nikolaidis P; Charokopos N; Theodoridis G
    Int J Antimicrob Agents; 2007 Jun; 29(6):742-4. PubMed ID: 17374477
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetic modeling and dosage adaptation of biapenem in Japanese patients during continuous venovenous hemodiafiltration.
    Ikawa K; Morikawa N; Ikeda K; Suyama H
    J Infect Chemother; 2008 Feb; 14(1):35-9. PubMed ID: 18297447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid pharmacokinetics in an obese patient.
    Mersfelder TL; Smith CL
    Am J Health Syst Pharm; 2005 Mar; 62(5):464, 467. PubMed ID: 15745906
    [No Abstract]   [Full Text] [Related]  

  • 14. Age and sex effects on the pharmacokinetics of linezolid.
    Sisson TL; Jungbluth GL; Hopkins NK
    Eur J Clin Pharmacol; 2002 Jan; 57(11):793-7. PubMed ID: 11868801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring: linezolid too?
    Richards GA; Brink AJ
    Crit Care; 2014 Sep; 18(5):525. PubMed ID: 25673559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous administration of linezolid in pneumonia: what is the level of proof?
    Mimoz O; Montravers P; Paiva JA
    Intensive Care Med; 2015 Jan; 41(1):157-9. PubMed ID: 25425443
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple-dose pharmacokinetics of linezolid during continuous venovenous haemofiltration.
    Meyer B; Kornek GV; Nikfardjam M; Karth GD; Heinz G; Locker GJ; Jaeger W; Thalhammer F
    J Antimicrob Chemother; 2005 Jul; 56(1):172-9. PubMed ID: 15905303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of linezolid in patients treated in a compassionate-use program.
    Meagher AK; Forrest A; Rayner CR; Birmingham MC; Schentag JJ
    Antimicrob Agents Chemother; 2003 Feb; 47(2):548-53. PubMed ID: 12543657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid underexposure in a hypothyroid patient on levothyroxine replacement therapy: a case report.
    Pea F; Cadeo B; Cojutti PG; Pecori D; Bassetti M
    Ther Drug Monit; 2014 Oct; 36(5):687-9. PubMed ID: 24646731
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
    Radej J; Krouzecky A; Stehlik P; Sykora R; Chvojka J; Karvunidis T; Novak I; Matejovic M
    Ther Drug Monit; 2011 Aug; 33(4):393-7. PubMed ID: 21654349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.